HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

ramipril-telmisartan

TERMINATED · PHASE3 · Hypertension, Type 2 Diabetes, Albuminuria

Not enough recruitment

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.